Hepatitis C Virus and Non-Hodgkin's Lymphomas

References

• Harcis N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84(45)1361–1392
   PubMedGoogle Scholar
• The non-Hodgkin's lymphoma pathologic classification group: NCI sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2123
   PubMed Web of Science ®Google Scholar
• Woods J.S., Polissar L., Severson R.K., et al. Soft tissue sarcoma and non-Hodgkin's lymphomas in relation to phenoxyher-bicide and chlorinated phenol exposure in western Washington. J. Natl. Cancer Inst. 1987; 78: 899–905
   PubMed Web of Science ®Google Scholar
• Hoar S.K., Blair A., Holmes F.F., et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986; 256: 1141–1148
   PubMed Web of Science ®Google Scholar
• Colton T. Herbicide exposure and cancer. JAMA 1986; 256: 1176–1179
   PubMed Web of Science ®Google Scholar
• Beebe G.W., Kato H., Land C. Studies on the mortality of A-bomb survivors: Mortality and radiation dose. Radial. Res. 1978; 75: 138–147
   PubMed Web of Science ®Google Scholar
• Louie S., Daoust P.R., Shwratz R.S. Immunodeficiency and the pathogenesis of non-Hodgkin's lymphoma. Semin. Oncol. 1980; 7: 267–273
   PubMed Web of Science ®Google Scholar
• Palackdharry C.S. The epidemiology of non-Hodgkin's lymphomas: why the increased incidence?. Oncology 1994; 8(8)67–73
   PubMedGoogle Scholar
• Linet M.S., Malker H.S., McLaughlin J.K., et al. Non-Hodgkin's lymphoma and occupation in Sweden: a registry based analysis. Br. J. Ind. Med. 1993; 50(1)79–84
   PubMedGoogle Scholar
• Hatzissabas I., Krueger G.R., Medina J.R., Bedoya V.A., Papadakis T. Environmental pollution and malignant lymphomas: a tentative contribution to geographic pathology. Anticancer. Res. 1993; 13(2)411–417
   PubMed Web of Science ®Google Scholar
• Spector B.D., Perry G.S., Kersey J.H. Genetically determined immunodeficiency disease (GDID) and malignancy: A report from the Immunodeficiency Cancer Registry. Clin. Immunol, lmmunopathol. 1978; 11: 12–19
   PubMedGoogle Scholar
• Talal N. Autoimmunity and lymphoid malignancy in New Zealand black mice. Prog. Clin. Immunol 1974; 2: 101–109
   PubMedGoogle Scholar
• Hanto D.W., Frizzera G., Gajl-Peczalska K.J., et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N. Engl. J. Med. 1982; 306: 913–918
   PubMed Web of Science ®Google Scholar
• Cleary M.L., Warnke R., Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. N. Engl. J. Med. 1984; 310: 477–81
   PubMed Web of Science ®Google Scholar
• Kinlen L.J., Shiel A. G. R., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br. Med. J. 1979; 7: 1461–1468
   Google Scholar
• Isomaki H.A., Hakulinen T., Joutsenlathi U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J. Chronic Dis. 1978; 31: 691–702
   PubMedGoogle Scholar
• Wyburn-Mason R. SLE and lymphoma. Lancet 1978; 1: 156–8
   Web of Science ®Google Scholar
• Kassan S.S. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 1978; 89: 888–892
   PubMed Web of Science ®Google Scholar
• De Vita S., Ferraccioli G., De Re V., et al. The polymerase chain reaction detects B cell clonalities in patients with Sjogren's syndrome and suspected malignant lymphoma. J. Rheumatol 1994; 21(8)1497–1501
   PubMed Web of Science ®Google Scholar
• Holmes G. T. K., Stokes P.L., Sorahan T.M., et al. Coeliac disease, gluten-free diet, and malignancy. Gut 1976; 17: 612–618
   PubMed Web of Science ®Google Scholar
• Brinker H., Wilbek E. The incidence of malignant tumors in patients with respiratory sarcoidosis. Br. J. Cancer 1974; 29: 247–253
   PubMed Web of Science ®Google Scholar
• Martin S.E., Martin W.J. Interspecies brain antigen detected by naturally occuring mouse anti-brain auto-antibody. Proc. Natl. Acad. Sci. USA 1975; 72: 1036–1041
   PubMed Web of Science ®Google Scholar
• Martin W.J., Martin S.E. Thymus reactive IgM auto-antibodies in normal mouse sera. Nature, 1975 1975; 254: 716–718
   Google Scholar
• Walford R.L. The immunological theory of aging. Munksgaard, Copenhagen 1969
   Google Scholar
• Dighiero G., Lymber P., Guilbert B., et al. Natural auto-antibodies constitute a substantial part of normal circulating im-munoglobulins. Ann. NY. Acad. Sci. 1986; 475: 135–145
   PubMed Web of Science ®Google Scholar
• Baccala R., Quang T.V., Gilbert M., et al. Two murinenatural polyreactive antibodies are encoded by nonmutated germ-line genes. Proc. Natl. Acad. Sci. USA 1989; 86: 4624–4628
   PubMed Web of Science ®Google Scholar
• Kofler R., Noonan D.J., Levy D.E., Wilson M.C. Genetic elements utilized for a murine lupus anti-DNA autoanti-body are closely related to those for antibodies to exogenous antigens. J. Exp. Med. 1985; 161: 805–815
   PubMed Web of Science ®Google Scholar
• Sela B.A., et al. Antibodies reactive with cell surface carbohydrates. Proc. Natl. Acad. Sci. USA 1975; 254: 716–718
   Google Scholar
• Dziarski R. Autoimmunity: polyclonal activation or antigen induction?. Immunol. Today 1988; 9: 340–342
   PubMedGoogle Scholar
• Klinman D., Steinberg A.D. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 1987; 165: 1755–1760
   PubMed Web of Science ®Google Scholar
• Kritzman J., Kunkel H.G., Me Carthy J. Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties. J. Lab. Clin. Med. 1961; 57: 905–912
   PubMed Web of Science ®Google Scholar
• Chen P.P., Kipps I.J., Liu F.T., Carson D.A. Isolation and characterization of a light chain variable region gene for human rheumatoid factors. J. Exp. Med 1987; 166: 1900–1912
   PubMed Web of Science ®Google Scholar
• Mayer R. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood 1991; 75: 1518–1524
   Web of Science ®Google Scholar
• Clearly M.L., Meeker T.C., Levy S. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 1986; 44: 97–105
   PubMed Web of Science ®Google Scholar
• Dighiero G., Travade P., Binet J.L. B-cell chronic lymphocytic leukemia: present status and future directions. Blood 1991; 78: 1901–1914
   PubMed Web of Science ®Google Scholar
• Shiramitzu B., Barriga F., Neequaye J., et al. Pattern of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77(7)1516–1526
   PubMed Web of Science ®Google Scholar
• Brousset P., Knecht H., Rubin B., et al. Demonstration of Epstein-Barr virus replication in Reed-Stemberg cells of Hodgkin's disease. Blood 1993; 82: 872–876
   PubMed Web of Science ®Google Scholar
• Gallo R.C. Human retrovirus: a decade of discovery and link with human disease. J. Inf. Dis. 1991; 164: 277–289
   PubMedGoogle Scholar
• Watherspoon A.C., Hortiz-Hidalgo C., Falzon M.R., Isaacson P.G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 338: 1175–1176
   PubMed Web of Science ®Google Scholar
• Kaplan L.D. AIDS-associated lymphomas. The Medical Menagement of AIDS, M.A. Sande, P.A. Volberdinger. Publ.: Saunders, Philadelphia 1988; 307–315
   Google Scholar
• Epstein M.A., Achang B.G., Barr Y.H. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702–706
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. EBV DNA in biopsies of Burkitt tumor and anaplastic carcinoma of the nasopharynx. Nature 1970; 228: 1056–1058
   PubMed Web of Science ®Google Scholar
• Wolf H., Hausen H.Z., Becker V., et al. EB-viral genomes in epithelial nasopharyngeal carcinoma cells. Nature 1973; 244: 245–247
   Web of Science ®Google Scholar
• Crawford D.H., Thompson J.H., Fernando O.N., et al. Epstein-Barr virus nuclear antigen positive lymphoma after Cyclosporin A treatment in patients with renal allograft. Lancet 1980; i: 1355–1356
   Web of Science ®Google Scholar
• Murphy J.K., Young L.S., Bevan I.S., et al. Demonstration of Epstein-Barr virus in primary lymphoma by in situ DNA hybridization in paraffin wax embedded tissue. J. Clin. Pathol. 1990; 43: 220–223
   PubMed Web of Science ®Google Scholar
• Jones J.F., Gottman D., Katz B.Z., Tubbs R.R. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N. Engl. J. Med. 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Kikuta H., Taguchi Y., Tomizawa K. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333: 455–457
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Imai S., Kataura A. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granu-loma. Lancet 1990; 335: 128–130
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Herbst H., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810–816
   PubMed Web of Science ®Google Scholar
• Weiss L.M., Movahed L.A., Warnke R.A. Detection of Epstein-Barr virus genomes in Reed-stemberg cells of Hodgkin's disease. N. Engl. J. Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Pallensen G. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Cheeseman S.H. Infectious mononucleosis. Sem. Hematol. 1988; 25: 261–268
   PubMed Web of Science ®Google Scholar
• Henle G., Henle W., Diehl V., et al. Relation of a Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 1968; 59: 94–101
   PubMed Web of Science ®Google Scholar
• Nemerow G.R., Moore M.D., Cooper N.R. Structure and function of the B-lymphocyte Epstein-Barr virus/CD3d receptor. Adv. Cancer Res. 1990; 54: 273–300
   PubMedGoogle Scholar
• Henderson S., Rowe M., Gregory C., Croom-Carter D. Induction of bcl-2 expression by Epstein-Barr virus Latent Membrane Protein-1 protects infected B cell from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D.A., Mann K.P. Early events in Epstein-Barr virus infection provide a model for B-cell activation. J. Exp. Med 1985; 162: 45–49
   PubMed Web of Science ®Google Scholar
• Rowe M., Hildreth J.E., Rickinson A.B., Epstein M.A. Monoclonal antibodies to Epstein-Barr virus-induced transformation-associated cell surface antigens: Binding patters and effect upon virus-specific cytotoxicity. Int. J. Cancer 1982; 29: 373–381
   PubMed Web of Science ®Google Scholar
• Magrath I. The pathogenesis of Burkitt's lymphoma. Adv. Cancer. Res. 1990; 55: 133–270
   PubMedGoogle Scholar
• Rowe M. Epstein-Barr virus and lymphoid malignancy. Recent advances in hematology, A.V. Hoffbrand, M. Brenner. Churcill Livingstone, London 1992; 6: 205–222
   Google Scholar
• Herbst H., Hummel M., Pileri S. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Stemberg cells. Proc. Natl. Acad. Sci. USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Ballerini P., Gaidano G., Gong J.Z., et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993; 81(1)166–176
   PubMed Web of Science ®Google Scholar
• Watherspoon A.C., Doglioni C., Diss T.C., et al. Regression of primary low-grade B-cell gastric lymphoma of mu-cosa-associated lymphoid tissue after eradication of Helicobacter pilori. Lancet 1993; 342: 575–577
   PubMed Web of Science ®Google Scholar
• Grey H.M., Kohler P.F. Cryoglobulins. Semin. Hematol. 1977; 10: 87–95
   Google Scholar
• Johnson R.J., Gretch D.R., Yamabe H., et al. Membranoproliferative glomerulo-nephritis associated with hepatitis C virus. N. Engl. J. Med 1993; 328: 465–71
   PubMed Web of Science ®Google Scholar
• Ferri C., Greco F., Longobardo G., et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin. Exp. Rheumatol. 1991; 9: 95–96
   PubMed Web of Science ®Google Scholar
• Agnello V., Chung R.T., Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia?. N. Engl. J. Med. 1992; 327: 1490–1496
   PubMed Web of Science ®Google Scholar
• Zignego A.L., Macchia D., Monti M., et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 1992; 15: 382–389
   PubMed Web of Science ®Google Scholar
• Ferri C., Monti M., La Civita L., et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701–3704
   PubMed Web of Science ®Google Scholar
• Mazzaro C., Santini G.F., Pozzato G., et al. Clinical and vi-rological findings in mixed cryoglobulinemia. J. Int. Med. 1995, in press
   PubMedGoogle Scholar
• Santini G.F., Crovatto M., Modolo M.L., et al. Waldenstrom's macroglobulinemia: a role of HCV infection?. Blood 1993; 9: 2932, (Letter)
   Google Scholar
• Broder S., Humphrey R., Drum M. Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by lymphocytes from patients with multiple myeloma. N. Engl. J. Med. 1975; 293: 887–891
   PubMed Web of Science ®Google Scholar
• Van Thiel D.H., Fagiuoli P., Caraceni H.I., et al. Cryoglobulinemia: a cause of false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J. Hepatol. 1995; 22(4)464–467
   PubMed Web of Science ®Google Scholar
• Mussini M., Mascia M.T., Zanni G., Curci G. Bone marrow for the diagnosis of essential mixed type II cryoglobulinemia. Haematologica 1991; 76: 389–391
   PubMed Web of Science ®Google Scholar
• Pozzato G., Mazzaro C., Crovatto M., et al. Mixed cryoglobulinemia, Non-Hodgkin's lymphomas and HCV infection. Blood 1994; 84(9)3047–3053
   PubMed Web of Science ®Google Scholar
• Gorevic P.D., Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative disease. Sem. Hematol. 1991; 28: 79–94
   PubMed Web of Science ®Google Scholar
• Efremov D.G., Batista F.D., Burrone O.R. Molecular analysis of IgE heavy chain transcript expressed in vivo by peripheral blood lymphocytes from normal and atopic individuals. J. Immunol. 1993; 151: 2195–2207
   PubMed Web of Science ®Google Scholar
• Franzin F., Pozzato G., Efremov D., et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br. J. Haematol. 1995, in press
   PubMedGoogle Scholar
• Pagliaro L., Saracci R., Bardelli D., Filippazzo G. Chronic liver disease, alcohol consumption and HBsAg in Italy: a multiregional case-control study. It. J. Gastroenterol. 1982; 14: 90–95
   Google Scholar
• D'Amico G., Morabito A., Pagliaro L., Marubini E., the liver study group of “Cervello” Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig. Dis. Sci. 1986; 31: 468–475
   PubMed Web of Science ®Google Scholar
• Bellentani S., Tiribelli C., Saccoccio G., et al. Prevalence of chronic liver disease in the general population of Northern Italy: the Dyonisos study. Hepatology 1994; 20(6)1442–1449
   PubMed Web of Science ®Google Scholar
• Houghton M., Weiner A., Han J., Kuo G., Choo Q.L. Molecular biology of the hepatitis C virus: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381–388
   PubMed Web of Science ®Google Scholar
• Sakamuro D., Furukawa T., Takegami T. Hepatitis C virus non-structural protein NS3 transform NIH 3T3 cells. J Virol. 1995; 69(6)3893–3896
   PubMedGoogle Scholar
• Simmonds P., Smith D.B., Mc Omish M., et al. Identification of genotypes of hepatitis C virus by sequence comparison in the Core, El and NS-5 regions. J. Gen. Virol. 1994; 75: 1053–1061
   PubMed Web of Science ®Google Scholar
• Okamoto H., Kojima M., Okada S-I., et al. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virology 1992; 190: 894–899
   PubMed Web of Science ®Google Scholar
• Pozzato G., Kaneko S., Moretti M., et al. Different genotypes of HCV are associated with chronic liver disease of different severity. J Med. Virol. 1994; 43: 291–296
   PubMed Web of Science ®Google Scholar
• Okamoto H., Sugiyama Y., Okada S., et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol 1992; 73: 673–679
   PubMed Web of Science ®Google Scholar
• Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 67: 570–583
   Google Scholar
• Brown E.A., Zhang H., Ping H-L., et al. Secondary structure of the 5′ nontranslated region of hepatitis C virus and pesti virus genomic RNAs. Nucleic Acids Res. 1992; 20: 5042–5045
   Google Scholar